Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the third quarter ...

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third ...

That hints at substantial gains in 2026 and investors can lean into that possibility by buying shares of Meta Platforms ( ...

Austin, Texas, United States, November 13th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage ...

Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.

BBOT debuted as a publicly traded company focused on optimized target coverage for patients with tumors driven by RAS and ...

He bought Nvidia at $101, rode the AI wave to solid gains, and then dumped everything.

The call will provide a corporate and financial update and go forward operational plans.

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...

Q2 2026 Earnings Call Transcript November 10, 2025 Beyond Air, Inc. misses on earnings expectations. Reported EPS is $-1.25 ...